Pacira BioSciences, Inc. (PCRX) NASDAQ
23.66
-0.0324(-0.14%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.15B |
| Enterprise Value | 1.45B |
| P/E Ratio | 103.04 |
| PEG Ratio | -1.82 |
| Price/Sales Ratio | 1.27 |
| Price/Book Ratio | 1.47 |
| Enterprise/Revenue | 1.63 |
| Enterprise/EBITDA | 10.93 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0.02 |
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.01 |
Income Statement
| Revenue | 726.41M |
| Revenue/Share | 18.16 |
| Gross Profit | 576.66M |
| EBITDA | 122.5M |
| Net Income | 7.03M |
| Diluted EPS | 0.16 |
Balance Sheet
| Total Cash | 202.18M |
| Total Cash/Share | 5 |
| Total Debt | 411.18M |
| Total Debt/Equity | 0.63 |
| Current Ratio | 4.73 |
| Book Value Per Share | 16.16 |
Price History
| 52-Week Change | -5.92 |
| 52-Week High | 27.64 |
| 52-Week Low | 18.8 |
| Moving Average 50 Days | 23.41 |
| Moving Average 200 Days | 23.67 |
Statistics
| Average Volume | 736,642 |
| Shares Outstanding | 39.34M |
| % Held by Institutions | 107.15 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
